Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).

Date Range:

	BioMarin Pharmaceutical	Elanco Animal Health	Zai Lab	Ono Pharmaceutical	Grifols
Symbol	NASDAQ:BMRN	NYSE:ELAN	NASDAQ:ZLAB	OTCMKTS:OPHLF	NASDAQ:GRFS
Price Information
Current Price	$75.60	$32.10	$145.56	$23.80	$18.12
52 Week Range	Buy	Buy	Buy	N/A	Buy
MarketRank™
Overall Score	2.1	1.8	1.6	0.9	1.3
Analysis Score	4.3	2.3	3.5	0.0	0.0
Community Score	3.1	2.2	2.4	2.2	2.1
Dividend Score	0.0	0.0	0.0	0.0	1.7
Ownership Score	1.7	2.5	1.7	0.0	0.0
Earnings & Valuation Score	1.3	1.9	0.6	2.5	2.5
Analyst Ratings
Consensus Recommendation	Buy	Hold	Buy	N/A	Buy
Consensus Price Target	$118.20	$32.23	$197.85	N/A	N/A
% Upside from Price Target	56.35% upside	0.40% upside	35.92% upside	N/A	N/A
Trade Information
Market Cap	$13.82 billion	$15.18 billion	$13.78 billion	$13.42 billion	$12.83 billion
Beta	0.71	0.86	0.95	1.06	0.59
Average Volume	1,200,365	3,885,239	494,355	2,767	848,847
Sales & Book Value
Annual Revenue	$1.70 billion	$3.07 billion	$12.98 million	$2.69 billion	$5.71 billion
Price / Sales	8.11	4.94	1,061.81	4.55	2.18
Cashflow	$0.58 per share	$1.95 per share	N/A	$1.09 per share	$1.56 per share
Price / Cash	130.22	16.48	N/A	21.92	11.58
Book Value	$17.38 per share	$14.87 per share	$5.07 per share	$10.16 per share	$11.15 per share
Price / Book	4.35	2.16	28.71	2.34	1.63
Profitability
Net Income	$-23,850,000.00	$67.90 million	$-195,070,000.00	$549.28 million	$700.16 million
EPS	$0.07	$1.06	($3.03)	$1.09	$1.17
Trailing P/E Ratio	17.30	N/A	N/A	21.64	16.18
Forward P/E Ratio	142.64	35.67	N/A	14.60	12.00
P/E Growth	3.89	4.13	N/A	N/A	1.30
Net Margins	45.74%	-8.45%	N/A	22.14%	12.79%
Return on Equity (ROE)	4.34%	3.43%	N/A	11.29%	10.65%
Return on Assets (ROA)	2.84%	2.04%	N/A	9.71%	4.79%
Dividend
Annual Payout	N/A	N/A	N/A	N/A	$0.14
Dividend Yield	N/A	N/A	N/A	N/A	0.77%
Three-Year Dividend Growth	N/A	N/A	N/A	N/A	-49.65%
Payout Ratio	N/A	N/A	N/A	N/A	11.97%
Years of Consecutive Dividend Growth	N/A	N/A	N/A	N/A	N/A
Debt
Debt-to-Equity Ratio	0.26%	0.67%	N/A	N/A	0.95%
Current Ratio	3.20%	1.75%	8.57%	2.78%	2.93%
Quick Ratio	2.38%	0.90%	8.46%	2.33%	1.33%
Ownership Information
Institutional Ownership Percentage	97.65%	86.83%	81.32%	N/A	15.15%
Insider Ownership Percentage	2.15%	0.12%	N/A	N/A	N/A
Miscellaneous
Employees	3,059	10,200	1,194	3,560	24,000
Shares Outstanding	182.74 million	473.00 million	94.69 million	514.12 million	687.55 million
Next Earnings Date	8/3/2021 (Estimated)	7/29/2021 (Estimated)	N/A	N/A	7/29/2021 (Estimated)
Optionable	Optionable	Optionable	Optionable	Not Optionable	Optionable

Source	Headline
	Plasma Expander Market 2021 Overview, Opportunities, In-Depth Analysis by 2027 : Grifols USA, LLC, Astrazeneca, Abbott, CSL Behring, Novartis, BioTime, Kedrion Biopharma Inc., Abbott, Biogen Idec – Test & Measurement - Test & Measurement testmeasurement.com.au - May 12 at 3:50 PM
	$0.31 Earnings Per Share Expected for Grifols, S.A. (NASDAQ:GRFS) This Quarter americanbankingnews.com - May 12 at 1:16 PM
	Global Blood Transfusion Market 2021 to 2026 Growth Forecast: B.Braun, TERUMO, Grifols, Fresenius Kabi – The Manomet Current - The Manomet Current manometcurrent.com - May 12 at 10:50 AM
	China'Human Serum Albumin Markets Report 2021: In 2020, Annual Growth Rate was 11.3%, A Slow Down Compared to that in 2019 Due to the COVID-19 Epidemic - Forecast to 2025 - Yahoo Finance finance.yahoo.com - May 12 at 10:50 AM
	Global Plasma Fractionation Market 2021 Overview, Opportunities, In-Depth Analysis by 2027 : RAAS, Octapharma, Biotest, BPL, Hualan Bio, Takeda, Kedrion, CSL Behring, LFB Group, Grifols, CBPO – Brockville Observer - Brockville Observer thebrockvilleobserver.ca - May 12 at 10:50 AM
	MAY E-NEWSLETTER: PRIORITIZE YOUR HEALTH THIS MAY \| Blood Clots - National Blood Clot Alliance stoptheclot.org - May 11 at 6:30 PM
	Grifols has an urgent need for Plasma donations - ABC 4 abc4.com - May 11 at 6:30 PM
	Parenteral Nutrition Products Market Quality & Quantity Analysis \| Baxter International, Hospira, B. Braun Melsungen, Grifols International, Fresenius Kabi – The Manomet Current - The Manomet Current manometcurrent.com - May 11 at 8:17 AM
	Investigation Report on China's Human Serum Albumin Markets, 2016-2020 & 2021-2025 - ResearchAndMarkets.com - Galveston County Daily News galvnews.com - May 10 at 9:08 PM
	Thrombin (Human) Market Development And Trends Forecasts 2021-2027:Shanghai RAAS, Grifols, Octapharma, Hualan Biological, Baxter, Bayer, CSL – Test & Measurement - Test & Measurement testmeasurement.com.au - May 10 at 9:08 PM
	Investigation Report on China's Human Serum Albumin Markets, 2016-2020 & 2021-2025 - ResearchAndMarkets.com - Business Wire businesswire.com - May 10 at 3:55 PM
	Prolastin Market R & D including top key players Grifols – Brockville Observer - Brockville Observer thebrockvilleobserver.ca - May 10 at 8:36 AM
	Human Hyperimmune Globulins Market 2021 Is Booming Worldwide \| Key Players:CSLBehring,Grifols,Biotest,Kedrion,CBPO – Lakes Business News - Lakes Business News lakesbusinessnews.com - May 10 at 8:36 AM
	Colloids (Blood Plasma) Market 2021-2029 Global Analysis : CSL Behring, Baxter, Grifols, Octapharma – Clark County Blog - Clark County Blog clarkcountyblog.com - May 8 at 6:45 PM
	Global Hyperimmune Serum Market 2021 Industry Scope – CSL Behring, Grifols, Biotest, Kedrion, CBPO – FLA News - FLA News flanewsonline.com - May 7 at 9:28 AM
	azValor Asset Management Buys - GuruFocus.com gurufocus.com - May 6 at 6:26 PM
	Grifols: Q1 Earnings Snapshot - CT Post ctpost.com - May 6 at 6:26 PM
	Grifols (NASDAQ:GRFS) Announces Earnings Results americanbankingnews.com - May 6 at 6:06 PM
	Analysts Conflicted on These Healthcare Names: Grifols SA (GRFS) and Genfit SA (GNFT) - Smarter Analyst smarteranalyst.com - May 6 at 3:25 AM
	Grifols: Q1 Earnings Snapshot - San Antonio Express-News expressnews.com - May 6 at 3:25 AM
	Grifols: Q1 Earnings Snapshot - The Edwardsville Intelligencer theintelligencer.com - May 5 at 5:24 PM
	Grifols reduces its profit by 30% in the first quarter of 2021, to 129.9 million - Born2Invest born2invest.com - May 5 at 11:48 AM
	Medical Consumables Market May See Big Move \| TERUMO, Fresenius, Grifols – The Shotcaller - The Shotcaller theshotcaller.net - May 5 at 11:48 AM
	Should You Buy Grifols SA - ADR ADR Class B (GRFS) Stock Tuesday? - InvestorsObserver investorsobserver.com - May 4 at 6:40 PM
	Grifols ADR Earnings, Revenue Miss in Q1 By Investing.com - Investing.com investing.com - May 4 at 6:40 PM
	Grifols (NASDAQ:GRFS) Stock Rating Reaffirmed by Berenberg Bank marketbeat.com - April 27 at 4:37 PM
	3 Health Care Stocks That Could Double by Year End marketbeat.com - February 11 at 10:50 AM

Date	Company	Brokerage	Action
4/28/2021	BioMarin Pharmaceutical	Wedbush	Reiterated Rating
4/26/2021	BioMarin Pharmaceutical	Credit Suisse Group	Initiated Coverage
4/26/2021	BioMarin Pharmaceutical	Morgan Stanley	Lower Price Target
3/8/2021	BioMarin Pharmaceutical	Evercore ISI	Upgrade
3/8/2021	BioMarin Pharmaceutical	Canaccord Genuity	Lower Price Target
3/1/2021	BioMarin Pharmaceutical	Robert W. Baird	Reiterated Rating
11/6/2020	BioMarin Pharmaceutical	SVB Leerink	Lower Price Target
9/10/2020	BioMarin Pharmaceutical	Truist	Lower Price Target
8/20/2020	BioMarin Pharmaceutical	Oppenheimer	Lower Price Target
8/20/2020	BioMarin Pharmaceutical	Jefferies Financial Group	Lower Price Target
8/20/2020	BioMarin Pharmaceutical	William Blair	Reiterated Rating
8/19/2020	BioMarin Pharmaceutical	Citigroup	Downgrade
8/19/2020	BioMarin Pharmaceutical	Royal Bank of Canada	Downgrade
8/19/2020	BioMarin Pharmaceutical	Stifel Nicolaus	Downgrade
5/11/2021	Elanco Animal Health	G.Research	Upgrade
5/11/2021	Elanco Animal Health	Gabelli	Upgrade
5/11/2021	Elanco Animal Health	Barclays	Upgrade
3/22/2021	Elanco Animal Health	Raymond James	Reiterated Rating
12/9/2020	Elanco Animal Health	Argus	Downgrade
11/17/2020	Elanco Animal Health	Citigroup Inc. 3% Minimum Coupon Principal Protected Based Upon Russell	Boost Price Target
8/4/2020	Elanco Animal Health	The Goldman Sachs Group	Initiated Coverage
7/27/2020	Elanco Animal Health	Cleveland Research	Downgrade
7/20/2020	Elanco Animal Health	Bank of America	Boost Price Target
4/13/2021	Zai Lab	Guggenheim	Boost Price Target
11/16/2020	Zai Lab	JPMorgan Chase & Co.	Boost Price Target
9/4/2019	Zai Lab	China Renaissance Securities	Initiated Coverage
7/5/2019	Zai Lab	Macquarie	Initiated Coverage
4/27/2021	Grifols	Berenberg Bank	Reiterated Rating
4/20/2021	Grifols	Deutsche Bank Aktiengesellschaft	Initiated Coverage
3/17/2021	Grifols	HSBC	Upgrade

(Data available from 5/12/2018 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Comparison Ideas:

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Your Ultimate Investing Toolkit

Just $1.00 for your first month.

Compare Stocks

30 Days of MarketBeat All Access for $1.00

Resources

Premium Research Tools

Market Data and Calendars

Investing Education and Resources